| 000 | 01648 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513101942.0 | ||
| 264 | 0 | _c19961024 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0091-3057 | ||
| 024 | 7 |
_a10.1016/0091-3057(95)00205-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarona-Lewicka, D | |
| 245 | 0 | 0 |
_aReinforcing effects of certain serotonin-releasing amphetamine derivatives. _h[electronic resource] |
| 260 |
_bPharmacology, biochemistry, and behavior _cJan 1996 |
||
| 300 |
_a99-105 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
| 650 | 0 | 4 |
_aAmphetamines _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aConditioning, Operant _xdrug effects |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDopamine Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aFenfluramine _xpharmacology |
| 650 | 0 | 4 |
_aIndans _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrodialysis |
| 650 | 0 | 4 |
_aN-Methyl-3,4-methylenedioxyamphetamine _xpharmacology |
| 650 | 0 | 4 |
_aNucleus Accumbens _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aReinforcement, Psychology |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin Agents _xpharmacology |
| 650 | 0 | 4 |
_aSerotonin Receptor Agonists _xpharmacology |
| 650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
| 700 | 1 | _aRhee, G S | |
| 700 | 1 | _aSprague, J E | |
| 700 | 1 | _aNichols, D E | |
| 773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 53 _gno. 1 _gp. 99-105 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0091-3057(95)00205-7 _zAvailable from publisher's website |
| 999 |
_c8842641 _d8842641 |
||